Sebastien Hotte Selected Research

Sebastien Hotte Research Topics

11	Prostatic Neoplasms (Prostate Cancer) 10/2021 - 09/2011
11	Neoplasms (Cancer) 01/2021 - 10/2007
4	Neoplasm Metastasis (Metastasis) 07/2020 - 08/2013
3	Renal Cell Carcinoma (Grawitz Tumor) 06/2010 - 03/2007
1	Thyroid Neoplasms (Thyroid Cancer) 10/2021
1	Colitis 01/2020
1	Diarrhea 01/2020
1	Deglutition Disorders (Dysphagia) 01/2017
1	Carcinoma (Carcinomatosis) 01/2017
1	Carcinogenesis 06/2012
1	Pain (Aches) 09/2011
1	Adenoid Cystic Carcinoma (Cylindroma) 08/2009
1	Cardiotoxicity 04/2008

4	DNA (Deoxyribonucleic Acid)IBA 12/2020 - 06/2012
3	Docetaxel (Taxotere)FDA Link 09/2014 - 09/2011
2	abirateroneIBA 10/2021 - 09/2014
2	enzalutamideIBA 10/2021 - 10/2014
2	Radium-223IBA 07/2020 - 10/2014
2	AndrogensIBA 01/2015 - 10/2014
2	Abiraterone AcetateIBA 10/2014 - 09/2014
2	OGX-011IBA 08/2013 - 09/2011
1	IodineIBA 10/2021
1	AntigensIBA 10/2021
1	Androgen Receptors (Androgen Receptor)IBA 01/2021
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 12/2020
1	Cell-Free Nucleic AcidsIBA 12/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	tremelimumabIBA 01/2020
1	durvalumabIBA 01/2020
1	PlatinumIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Panitumumab (Vectibix)FDA Link 01/2017
1	Cisplatin (Platino)FDA LinkGeneric 01/2017
1	GlycopeptidesIBA 10/2016
1	CarbohydratesIBA 10/2016
1	VaccinesIBA 10/2016
1	Prednisone (Sone)FDA LinkGeneric 10/2014
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 09/2014
1	Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA 09/2014
1	ClusterinIBA 08/2013
1	Biomarkers (Surrogate Marker)IBA 08/2013
1	Antisense OligonucleotidesIBA 08/2013
1	taxaneIBA 09/2011
1	Mitoxantrone (Novantrone)FDA LinkGeneric 09/2011
1	Interferon-alpha (Interferon Alfa)IBA 06/2010
1	ErbB Receptors (EGF Receptor)IBA 08/2009
1	Lapatinib (GW572016)FDA Link 08/2009
1	human ERBB2 proteinIBA 08/2009
1	Tyrosine Kinase InhibitorsIBA 08/2009
1	Sunitinib (Sutent)FDA Link 04/2008
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 10/2007
1	Interleukin-2 (IL2)IBA 03/2007